World's Best Scientists 2026 revealed!
Anne-Geneviève Marcelin

Anne-Geneviève Marcelin

D-Index & Metrics

Immunology

D-Index
71
Citations
17329
World Ranking
2329
National Ranking
91

Anne-Geneviève Marcelin publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Anne-Geneviève Marcelin sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 520 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Anne-Geneviève Marcelin D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Anne-Geneviève Marcelin sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 71 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Anne-Geneviève Marcelin is a researcher affiliated with Sorbonne University in France, specializing in Medicine with a strong focus on Infectious Diseases, Virology, and Epidemiology. Their work covers a range of topics related to viral infections and clinical research, with significant contributions to the understanding of SARS-CoV-2, HIV/AIDS, and related infectious disease challenges.

The scientist has published extensively in areas including SARS-CoV-2 and COVID-19 research, HIV/AIDS drug development and treatment, and long-term effects of COVID-19. Their research portfolio includes studies on viral load dynamics, immune response, and pathogen detection methods, contributing to enhanced knowledge in clinical infectious diseases.

Key recent papers by Anne-Geneviève Marcelin include:

  • Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers, 2021, Nature Communications
  • The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients, 2021, Journal of Infection
  • Occurrence of Invasive Pulmonary Fungal Infections in Patients with Severe COVID-19 Admitted to the ICU, 2020, American Journal of Respiratory and Critical Care Medicine
  • Viral loads in clinical samples of men with monkeypox virus infection: a French case series, 2022, The Lancet Infectious Diseases
  • Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient, 2020, Emerging infectious diseases

Frequent co-authors collaborating with Marcelin include:

  • Vincent Cálvez
  • Stéphane Marot
  • Cathia Soulié
  • Aude Jary
  • Basma Abdi

Anne-Geneviève Marcelin commonly publishes in several scientific venues, with notable numbers of publications in:

  • Journal of Antimicrobial Chemotherapy
  • Journal of Infection
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • Frontiers in Immunology

The main fields of study that Marcelin contributes to include:

  • Medicine

Subfields of focus incorporate:

  • Infectious Diseases
  • Virology
  • Epidemiology
  • Oncology
  • Neurology

Primary topics addressed in Marcelin's research are:

  • SARS-CoV-2 and COVID-19 Research
  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • COVID-19 Clinical Research Studies
  • HIV/AIDS Research and Interventions
  • Long-Term Effects of COVID-19
  • SARS-CoV-2 detection and testing

Best Publications

  • Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover

    Jorge R. Almeida;David A. Price;David A. Price;Laura Papagno;Zaïna Aït Arkoub

  • Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy.

    Ana Canestri;Franæois-Xavier Lescure;Stephane Jaureguiberry;Antoine Moulignier

  • Mutations Associated with Failure of Raltegravir Treatment Affect Integrase Sensitivity to the Inhibitor In Vitro

    Isabelle Malet;Olivier Delelis;Marc-Antoine Valantin;Brigitte Montes

  • Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial

    Collins C Iwuji;Collins C Iwuji;Joanna Orne-Gliemann;Joseph Larmarange;Eric Balestre

  • Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136.

    Christine Katlama;Marc A Valantin;Michele Algarte-Genin;Claudine Duvivier

  • Rituximab therapy for HIV-associated Castleman disease.

    Anne-Geneviève Marcelin;Laurent Aaron;Christine Mateus;Emmanuel Gyan

  • Tetherin Restricts Productive HIV-1 Cell-to-Cell Transmission

    Nicoletta Casartelli;Marion Sourisseau;Jerome Feldmann;Florence Guivel-Benhassine

  • Characterization and structural analysis of HIV-1 integrase conservation

    Francesca Ceccherini-Silberstein;Isabelle Malet;Roberta D'Arrigo;Andrea Antinori

  • Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers.

    Stéphane Marot;Isabelle Malet;Valentin Leducq;Karen Zafilaza

  • Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma--associated herpesvirus infection in patients with and without Kaposi sarcoma.

    Jasjit Gill;Dimitra Bourboulia;John Wilkinson;Peter Hayes

  • Thymidine analogue reverse transcriptase inhibitors resistance mutations profiles and association to other nucleoside reverse transcriptase inhibitors resistance mutations observed in the context of virological failure

    Anne-Geneviève Marcelin;Constance Delaugerre;Marc Wirden;Pedro Viegas

  • The G140S mutation in HIV integrases from raltegravir-resistant patients rescues catalytic defect due to the resistance Q148H mutation.

    Olivier Delelis;Isabelle Malet;Li Na;Luba Tchertanov

  • The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients.

    Elisa Teyssou;Héloise Delagrèverie;Benoit Visseaux;Sidonie Lambert-Niclot

  • Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma.

    Anne-Geneviève Marcelin;Roland Tubiana;Sidonie Lambert-Niclot;Gilles Lefebvre

  • Occurrence of Invasive Pulmonary Fungal Infections in Patients with Severe COVID-19 Admitted to the ICU.

    Arnaud Fekkar;Alexandre Lampros;Julien Mayaux;Corentin Poignon

  • Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient.

    Marion Blaize;Julien Mayaux;Cécile Nabet;Alexandre Lampros

  • Identification of Kaposi's Sarcoma-Associated Herpesvirus (KSHV)-Specific Cytotoxic T-Lymphocyte Epitopes and Evaluation of Reconstitution of KSHV-Specific Responses in Human Immunodeficiency Virus Type 1-Infected Patients Receiving Highly Active Antiretroviral Therapy

    John Wilkinson;Alethea Cope;Jas Gill;Dimitra Bourboulia

  • Low T Cell Responses to Human Herpesvirus 8 in Patients with AIDS-Related and Classic Kaposi Sarcoma

    Amélie Guihot;Nicolas Dupin;Anne-Geneviève Marcelin;Isabelle Gorin

  • Evolution of viral quasispecies during SARS-CoV-2 infection.

    Aude Jary;Valentin Leducq;Isabelle Malet;Stéphane Marot

  • Outcome of kidney transplant recipients with previous human herpesvirus-8 infection.

    C. Frances;C. Mouquet;A. G. Marcelin;S. Barete

  • Genotypic Inhibitory Quotient as Predictor of Virological Response to Ritonavir-Amprenavir in Human Immunodeficiency Virus Type 1 Protease Inhibitor-Experienced Patients

    Anne-Geneviève Marcelin;Claire Lamotte;Constance Delaugerre;Nadine Ktorza

  • Role of HIV-1 minority populations on resistance mutational pattern evolution and susceptibility to protease inhibitors.

    Bénédicte Roquebert;Isabelle Malet;Marc Wirden;Roland Tubiana

Frequent Co-Authors

Vincent Calvez
Vincent Calvez Centre national de la recherche scientifique, CNRS
Christine Katlama
Christine Katlama Sorbonne University
Gilles Peytavin
Gilles Peytavin Claude Bernard University Lyon 1
Constance Delaugerre
Constance Delaugerre Université Paris Cité
Nicolas Dupin
Nicolas Dupin Université Paris Cité
Bernard Masquelier
Bernard Masquelier University of Bordeaux
Guislaine Carcelain
Guislaine Carcelain Université Paris Cité
Jacques Izopet
Jacques Izopet Federal University of Toulouse Midi-Pyrénées

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens the door to various healthcare and research careers. For those interested in clinical work, pursuing a Nurse Practitioner degree can be a viable option. Finding which nurse practitioner program is easiest can help prospective students balance demanding coursework with other commitments.

Mental health is a growing area within healthcare, and specialized online programs like the online PMHNP programs with clinical placement provide essential hands-on experience. These placements are critical for gaining real-world skills that complement theoretical knowledge.

Cost is a key factor in higher education decisions. Thankfully, there are many options, such as the cheapest online PMHNP programs, which make advanced degrees more accessible without compromising quality.

Understanding financial outcomes is equally important. Students and professionals can explore DNP salary transparency to make informed career choices based on location and specialization within nursing and immunology-related fields.

Best Scientists Citing Anne-Geneviève Marcelin

Trending Scientists

Recently Published Articles